Universal Ibogaine Inc. (IBOGF)
USD 0.02
(-11.05%)
USD 0.02
(-11.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | 497.15 Thousand CAD | 112.97% |
| 2021 | -3.83 Million CAD | -1000900.0% |
| 2020 | 383.00 CAD | 101.13% |
| 2019 | -33.86 Thousand CAD | -152.95% |
| 2018 | 63.95 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -144.95 Thousand CAD | 11.53% |
| 2023 Q1 | -163.83 Thousand CAD | -274.26% |
| 2023 Q3 | 68.08 Thousand CAD | 146.97% |
| 2022 Q4 | -43.77 Thousand CAD | -125.77% |
| 2022 FY | 497.15 Thousand CAD | 112.97% |
| 2022 Q3 | 169.89 Thousand CAD | -43.6% |
| 2022 Q2 | 301.22 Thousand CAD | 119.62% |
| 2022 Q1 | -1.53 Million CAD | -8182.76% |
| 2021 Q3 | 60.29 Thousand CAD | 998.21% |
| 2021 FY | -3.83 Million CAD | -1000900.0% |
| 2021 Q1 | 31.18 Thousand CAD | -19.8% |
| 2021 Q4 | -18.53 Thousand CAD | -130.74% |
| 2021 Q2 | 5490.00 CAD | -82.39% |
| 2020 Q1 | 4987.00 CAD | 133.42% |
| 2020 Q2 | -4393.00 CAD | -188.09% |
| 2020 Q4 | 38.88 Thousand CAD | 164.29% |
| 2020 FY | 383.00 CAD | 101.13% |
| 2020 Q3 | 14.71 Thousand CAD | 434.9% |
| 2019 Q3 | -13.02 Thousand CAD | -215.0% |
| 2019 FY | -33.86 Thousand CAD | -152.95% |
| 2019 Q4 | -14.92 Thousand CAD | -14.61% |
| 2019 Q2 | 11.32 Thousand CAD | 221.37% |
| 2019 Q1 | -9329.00 CAD | 59.14% |
| 2018 Q2 | 64.69 Thousand CAD | 136.15% |
| 2018 Q1 | -178.95 Thousand CAD | -85.51% |
| 2018 Q3 | -41.41 Thousand CAD | -164.02% |
| 2018 Q4 | -22.83 Thousand CAD | 44.87% |
| 2018 FY | 63.95 Thousand CAD | 0.0% |
| 2017 Q4 | -96.47 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | -17.84 Million USD | 102.786% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 109.855% |
| CSL Limited | 3.7 Billion USD | 99.987% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 99.393% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 172.371% |
| BioStem Technologies, Inc. | -7.77 Million USD | 106.391% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 139.582% |
| Qrons Inc. | -643.67 Thousand USD | 177.236% |
| Nascent Biotech, Inc. | -2.22 Million USD | 122.295% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 100.896% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 107.478% |
| Skye Bioscience, Inc. | -13.67 Million USD | 103.636% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 219.657% |
| Rebus Holdings, Inc. | -664 Thousand USD | 174.872% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 103.133% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 137.228% |
| Genscript Biotech Corporation | -415.79 Million USD | 100.12% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 227.615% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 100.693% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 89.885% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 289.951% |
| SQZ Biotechnologies Company | -75.82 Million USD | 100.656% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 117.441% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 132.366% |
| Mesoblast Limited | -84.14 Million USD | 100.591% |
| Marizyme, Inc. | -34.08 Million USD | 101.458% |
| Genus plc | 6.4 Million USD | 92.232% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 94.897% |
| Pharming Group N.V. | -4.87 Million USD | 110.188% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 125.027% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 153.378% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 105.954% |
| ContraFect Corporation | -56.88 Million USD | 100.874% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 110.915% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 135.46% |
| IMV Inc. | -38.67 Million USD | 101.286% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 118.073% |
| MultiCell Technologies, Inc. | -722.81 USD | 68880.316% |
| ONE Bio Corp. | 13.68 Million USD | 96.366% |
| Accustem Sciences Inc. | -3.74 Million USD | 113.27% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 100.843% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | 202.917% |
| Q BioMed Inc. | -3.44 Million USD | 114.429% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 85.956% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 118.921% |
| Biomind Labs Inc. | -1 Million USD | 149.242% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 100.904% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 117.136% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 126.666% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 1759.826% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 125.724% |
| GB Sciences, Inc. | -1.42 Million USD | 134.998% |
| Alpha Cognition Inc. | -9.7 Million USD | 105.122% |
| HST Global, Inc. | -140.9 Thousand USD | 452.822% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 144.195% |
| Halberd Corporation | -75.05 Thousand USD | 762.426% |
| Enzolytics Inc. | -2.14 Million USD | 123.136% |
| Agentix Corp. | -1.37 Million USD | 136.242% |
| Resverlogix Corp. | -12.74 Million USD | 103.9% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 115.692% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -425.04 Million USD | 100.117% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 147.62% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 117.029% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 131.478% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 114.601% |
| AVAX Technologies, Inc. | 6.69 Million USD | 92.572% |
| Zenith Capital Corp. | -8.94 Million USD | 105.559% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 2953.745% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 120.248% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 389.868% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 124.799% |
| Kadimastem Ltd | -3.04 Million USD | 116.352% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 150.521% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 373.935% |
| LadRx Corporation | -3.82 Million USD | 113.002% |
| Cell Source, Inc. | -4.32 Million USD | 111.494% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 172.371% |
| NovAccess Global Inc. | -2.46 Million USD | 120.154% |
| Affymax, Inc. | -15.04 Million USD | 103.304% |
| Itoco Inc. | -919.14 Thousand USD | 154.089% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 111.73% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 144.428% |
| Mobile Lads Corp. | -554.55 Thousand USD | 189.649% |
| CytoDyn Inc. | -18.05 Million USD | 102.753% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 2075.173% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 325.898% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 188.034% |
| SYBLEU INC | -149.18 Thousand USD | 433.256% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 127.371% |
| International Stem Cell Corporation | -663 Thousand USD | 174.985% |
| Bioxytran, Inc. | -3.82 Million USD | 113.014% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 1044.436% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 2544.204% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 101.371% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 130.726% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 167.563% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 115.98% |
| Neutra Corp. | -229.48 Thousand USD | 316.637% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 102.835% |
| PureTech Health plc | -146.19 Million USD | 100.34% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 102.313% |
| IXICO plc | -1.43 Million USD | 134.596% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 105.238% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 100.408% |
| CSL Limited | 3.81 Billion USD | 99.987% |
| Cellectis S.A. | -108.85 Million USD | 100.457% |